Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Don Chin

Diagnostic Radiology Redding, CA Medical Doctor

NPI 1316967557 CMS profile 150471

2020 Court St, Redding, CA 96001

Open in the dashboard

General payments

$5,980

86 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Don Chin of Redding, CA is reported in the CMS Open Payments database as having received $5,980 across 86 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $510 18
2024 General $2,493 15
2023 General $2,112 26
2022 General $46 2
2021 General $411 16
2020 General $122 3
2019 General $285 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Don Chin
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Don Chin were reported at $510. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Don Chin Diagnostic Radiology median Middle half National median
2019 $285 $108 $29–$318 $163
2020 $122 $65 $21–$252 $114
2021 $411 $92 $24–$292 $132
2022 $46 $104 $29–$294 $149
2023 $2,112 $110 $29–$337 $160
2024 $2,493 $113 $30–$356 $164
2025 $510 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $2,451 6 payments
  2. Intuitive Surgical, Inc. $1,500 1 payment
  3. Inari Medical, Inc. $765 34 payments
  4. Medtronic, Inc. $430 18 payments
  5. Bard Peripheral Vascular, Inc. $252 11 payments
  6. Stryker Corporation $231 9 payments
  7. Biocompatibles, Inc. $143 1 payment
  8. Boston Scientific Corporation $124 2 payments
  9. EKOS Corporation $34 1 payment
  10. Cardinal Health 200, LLC $17 1 payment
  11. Other $33 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Long term medical supply or device loan $2,333 1 payment
  2. Food and Beverage $2,147 84 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,500 1 payment
Products named General payments · program years 2019–2025
  1. Auryon Laser System 100-120 Vac $2,333 1 payment
  2. DA VINCI SP $1,500 1 payment
  3. FLOWTRIEVER CATHETER, S $954 41 payments
  4. CT THROMBECTOMY SYSTEM KIT $800 37 payments
  5. Pipeline $190 4 payments
  6. THERASPHERE-BIO $143 1 payment
  7. GENERAL VASCULAR INTERVENTION $106 1 payment
  8. IN.PACT Admiral $93 5 payments
  9. COVERA $60 4 payments
  10. ARTIX MT $56 2 payments
  11. Other $464 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 180 billing codes

Paid by Medicare

$225,424

Of which drugs: $447

Medicare patients

1,613

Average age 74

Services billed

6,170

829 women, 784 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 48%
Diabetes 39%
Ischemic heart disease 37%
Chronic kidney disease 35%
Heart failure 32%
COPD 30%
Atrial fibrillation 28%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 34 3,631 $354
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 Office 12 99 $29

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record